Role of IKK and oscillatory NFκB kinetics in MMP-9 gene expression and chemoresistance to 5-fluorouracil in RKO colorectal cancer cells

被引:35
作者
Fukuyama, Ryuichi
Ng, Kwok Peng
Cicek, Muzaffer
Kelleher, Clare
Niculaita, Roxana
Casey, Graham
Sizemore, Nywana
机构
[1] Cleveland Clin, Dept Canc Biol, Cleveland, OH 44195 USA
[2] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA
关键词
NF kappaB; metalloproteinase-9; 5-fluorouracil; TNF-alpha; colorectal cancer;
D O I
10.1002/mc.20288
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nuclear factor kappa B (NF kappa B) is a central participant in the metastasis and chemoresistance of colorectal cancer (CRC). However, it is not fully understood to what extent NF kappa B contributes to induction of the metastasis-associated matrix metalloprotease-9 (MMP-9) gene and sensitivity to the commonly used chemotherapeutic 5-fluorouracil (5-Fu) in CRC. Using the RKO human CRC cell line and two NF kappa B signaling deficient RKO mutants, we investigated NF kappa B's role in the induction of MMP-9 and 5-Fu sensitivity in RKO CRC cells. NF kappa B plays a predominant role in MMP-9 gene induction in RKO cells, as evidenced by the failure of tumor necrosis factor alpha (TNF alpha) to induce MMP-9 in either of the NF kappa B signaling mutants, RKO cells exhibit a robust, oscillatory NF kappa B activity in response to TNF alpha not seen in either of the NF alpha B mutant cell lines, which instead demonstrate diminished, nonoscillatory NF kappa B activation. Analysis of TNF alpha-induced phosphorylati(on and MMP-9 promoter recruitment of the p65 NF kappa B subunit revealed a significant reduction in p65 phosphorylation as well as reduced and altered recruitment of p65 to the MMP-9 gene promoter in the mutants compared to the parental RKO cell line. 5-Fu only activated NF kappa B in the parental RKO cells through induction of I kappa B-kinase (IKK) activity and increased sensitivity to 5-Fu is observed in both NF kappa B mutant lines. Our results suggest that TIN F alpha-dependent induction of MMP-9 gene expression is tightly regulated by oscillatory/ cumulative activation of NF kappa,B and that 5-Fu stimulates NF kappa B and RKO CRC cell survival through induction of IKK activity. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:402 / 413
页数:12
相关论文
共 20 条
[1]   Evidence that activation of nuclear factor-κB is essential for the cytotoxic effects of doxorubicin and its analogues [J].
Ashikawa, K ;
Shishodia, S ;
Fokt, L ;
Priebe, W ;
Aggarwal, BB .
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (02) :353-364
[2]   5-Fluorouracil suppression of NF-κB is mediated by the inhibition of IκB kinase activity in human salivary gland cancer cells [J].
Azuma, M ;
Yamashita, T ;
Aota, K ;
Tamatani, T ;
Sato, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (01) :292-296
[3]  
Cusack JC, 2000, CANCER RES, V60, P2323
[4]   Age-dependent decline in the apolipoprotein e level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease [J].
Fukuyama, R ;
Mizuno, T ;
Mori, S ;
Yanagisawa, K ;
Nakajima, K ;
Fushiki, S .
EUROPEAN NEUROLOGY, 2000, 43 (03) :161-169
[5]   Coactivators and corepressors of NF-κB in IκΒα gene promoter [J].
Gao, ZG ;
Chiao, P ;
Zhang, X ;
Zhang, XH ;
Lazar, MA ;
Seto, E ;
Young, HA ;
Ye, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (22) :21091-21098
[6]   Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences [J].
Gum, R ;
Lengyel, E ;
Juarez, J ;
Chen, JH ;
Sato, H ;
Seiki, M ;
Boyd, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) :10672-10680
[7]   Matrix metalloproteinase inhibitors: How can we optimize their development? [J].
Hidalgo, M ;
Eckhardt, SG .
ANNALS OF ONCOLOGY, 2001, 12 (03) :285-287
[8]   The IκB-NF-κB signaling module:: Temporal control and selective gene activation [J].
Hoffmann, A ;
Levchenko, A ;
Scott, ML ;
Baltimore, D .
SCIENCE, 2002, 298 (5596) :1241-1245
[9]  
John Anitha, 2001, Pathology and Oncology Research, V7, P14
[10]  
Matter H, 2004, CURR OPIN DRUG DISC, V7, P513